Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

Samankaltaisia teoksia

• Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
  Tekijä: Patick, A K, et al.
  Julkaistu: (1995)
• Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.
  Tekijä: Deminie, C A, et al.
  Julkaistu: (1996)
• Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
  Tekijä: Bechtold, C M, et al.
  Julkaistu: (1995)
• Potentiation of the stavudine anti-human immunodeficiency virus activity by 5-fluorouracil.
  Tekijä: Gong, Y F, et al.
  Julkaistu: (1996)
• Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
  Tekijä: Kaplan, A H, et al.
  Julkaistu: (1994)